Sarah E. Parzych

University of Colorado Anschutz Medical Campus

MedicineImmunology and MicrobiologyChemistry

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Ex Vivo Efficacy of SAR442257 Anti-CD38 Trispecific T-cell Engager in Multiple Myeloma Relapsed After Daratumumab and BCMA-targeted Therapies”.

Ex Vivo Efficacy of SAR442257 Anti-CD38 Trispecific T-cell Engager in Multiple Myeloma Relapsed After Daratumumab and BCMA-targeted Therapies

Cancer Research Communications(2024)10.1158/2767-9764.crc-23-0434

N/A

0DataRank · unranked

18 citations

Lauren T. Reiman, Olivia Perez de, Sarah E. Parzych, Peter A. Forsberg, Peter Kim +5 more

MYC Inhibition Potentiates CD8+ T Cells Against Multiple Myeloma and Overcomes Immunomodulatory Drug Resistance

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-0256

N/A

0DataRank · unranked

15 citations

Zachary J. Walker, Lauren T. Reiman, Sarah E. Parzych, Brett M. Stevens, Craig T. Jordan +3 more